Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

2 recruiting4 with results

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06830980Not ApplicableRecruiting

Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH

Role: lead

NCT05049460Not ApplicableCompleted

Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder

Role: lead

NCT05295953Not ApplicableCompleted

Accelerated Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)

Role: lead

NCT07019571Not ApplicableRecruiting

tDCS and Urge in BFRBs

Role: lead

NCT06060496Not ApplicableCompleted

Theta Burst Stimulation for Alcohol Use Disorder

Role: lead

NCT06100731Not ApplicableCompleted

tDCS and Inhibitory Control in PTSD

Role: lead

NCT04936594Not ApplicableCompleted

TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)

Role: lead

All 7 trials loaded